SeqLL Inc.
SeqLL Inc.
Your view on SQLLW
Overview
What the company does, where it operates, and who runs it.
About SeqLL Inc.
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- Jeffrey Jagid
- Headquarters
- 3 Federal Street, Billerica, DE, US
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- Jeffrey Jagid
- Headquarters
- 3 Federal Street, Billerica, DE, US
SeqLL Inc. operates globally as a life science instrumentation and specialized research services firm. Its core objective is to pioneer the development of scientific assets and proprietary intellectual property across various "omics" disciplines. Central to SeqLL's offerings is its innovative True Single Molecule Sequencing (tSMS) platform. This advanced technology provides a direct single-molecule solution for both DNA and RNA sequencing by precisely detecting individual nucleic acids. It enables researchers to analyze billions of distinct molecules in a single experimental run, thereby generating highly accurate and reproducible data. The company's solutions address a range of applications, including biomarker discovery and the creation of diagnostic assays. Its clientele is diverse, encompassing academic institutions, dedicated scientific research centers, government agencies, and companies in the biotechnology and pharmaceutical sectors. SeqLL is actively involved in numerous collaborations to further its technology and explore new applications. These include a research and development partnership with the U.S. Department of Justice's Federal Bureau of Investigation (FBI) to evaluate the forensic capabilities of direct RNA sequencing using the tSMS platform. Another significant alliance is with True Bearing Diagnostics, Inc., where tSMS is being employed to analyze whole-blood RNA to identify transcripts associated with coronary artery disease. Further collaborations extend to: The Bernstein Laboratory, focusing on fundamental questions in chromatin biology and epigenetic regulation; The Ting Laboratory; The Jackson Laboratory for Genomic Medicine, where SeqLL assists in developing novel methods for single-molecule resolution chromatin interaction analysis in individual nuclei; the Weizmann Institute of Science, recognized for its development and application of innovative single-molecule technologies; and Tetracore, Inc., to whom SeqLL supplies tSMS systems and provides on-site support. Founded in 2013, SeqLL Inc. is headquartered in Billerica, Massachusetts.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
FRC's fair value estimate for SeqLL Inc., and the rating behind it. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for SeqLL Inc.. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for SeqLL Inc.. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for SeqLL Inc.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for SeqLL Inc.. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
SeqLL Inc. valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
Which funds and firms own the stock.
Which institutions hold SeqLL Inc., and how their positions are changing. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
Buying and selling by SeqLL Inc. executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming SeqLL Inc.. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming SeqLL Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
Latest headlines and company announcements for SeqLL Inc.. Press releases and market coverage, newest first.